With the latest developments in allowable adjustments for both isocratic and gradient compendial methods for USP, industries following USP guidelines can now modernize the HPLC methods to address their organizational goals. These goals include faster methods for a more rapid release, reduced extra work for method revalidation, reduced solvent consumption for a better and safer lab environment, and reduced cost per sample.

Save 45-75%*
time

Save 40-70%*
more solvent

Reduce hazardous
waste

A guide to updating HPLC compendial methods in pharmaceutical analysis.
Webinar available in English, Spanish, French, Italian and German.
Learn more about:
Key learning objectives:
Attendees will be equipped with an understanding of the vital role of compendial methods in pharmaceutical analysis, and how by making adjustments to them they can increase laboratory efficiency and decrease costs.
Who should attend:
Individuals interested in acquiring knowledge about the enhancement of HPLC compendial methods in pharmaceutical analysis or those seeking to leverage the most recent advancements in HPLC column technology to expedite their methods and reduce solvent costs are encouraged to participate. Embracing sustainability for the future is a key focus.
Explore our latest application notes and take advantage of our interactive cost savings calculators. Customize your own costs, assumptions, and method settings to visualize potential savings when employing our cutting-edge instruments. Uncover the efficiency and value our tools can bring to your operations.
Analysis of insulin using Agilent InfinityLab Poroshell 120 columns and following the newly revised USP <621> guidelines.
Gradient method transfer of the iohexol USP monograph HPLC method for related compounds to smaller particle size ZORBAX columns.
Method transfer to UHPLC conditions according to USP Chapter <621> requirements, using the Agilent 1260 Infinity II Prime LC System.
Method transfer to UHPLC conditions according to USP Chapter 621 requirements using an Agilent 1260 Infinity II Prime LC.